Update: the "Contiform" intravaginal device in four sizes for the treatment of stress incontinence.
The aim of this study was to evaluate the efficacy of the Contiform intravaginal device for stress incontinence after the addition of a fourth size. We offered the device to a cohort of 73 women with a main complaint of stress incontinence but no prolapse. Of the 73 women invited to participate, 65 enrolled, of whom 52 were fitted. Of these 52 women, 37 (71%) completed the study protocol. Outcome measures were the 24-h pad test, St George score, and quality of life tests. Urine loss on pad test was significantly reduced from a median 6.6 g (interquartile range [IQR] = 4.3-22.6) to 2.2 g (IQR = 0.5-8.2; P = 0.0016) after 4 weeks with significant benefit seen on the Incontinence Impact Questionnaire and Urinary Distress Inventory. The insertion technique was quickly learnt, and the device was well tolerated. The recently developed medium/large size of Contiform was used by 6/37 (16%) women.
Allen
W A
WA
Pelvic Floor Unit, St George Hospital, Gray St, Kogarah, NSW 2217, Australia.
Leek
H
H
Izurieta
A
A
Moore
K H
KH
D000328:Adult; D004867:Equipment Design; D005260:Female; D006801:Humans; D008875:Middle Aged; D010570:Pessaries; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000628:therapy*